XOMA Royalty Corp
XOMADelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000791908
XOMA Royalty Corp was delisted in 2026; its insiders filed their last Form 4 on Jul 16, 2026; 98 institutions reported holding it in 13F filings for Q2 2026, worth $723.7M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 98
- Q2 2026, +14 vs. previous quarter
- 13F value
- $723.7M
- Reported value at the end of Q2 2026
- Superinvestors holding
- 0
- At the end of Q2 2026
Superinvestors holding XOMA, Q2 2026
No superinvestor reported holding XOMA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by XOMA Royalty Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Hughes OwenChief Executive Officer | PPurchaseDepositary Shares - 8.375% B Cumulative Stock | +100.0K | $25.05 | +$2.50M | +5,000.0%102.0K after | |
| Sep 23, 2025 (view filing) | Sep 22 | 1 day | Burns Thomas M.SVP, Finance & CFO | SSale | −4.33K | $35.99 | −$155.8K | −12.6%30.1K after | 3 lots |
| Jul 2, 2025 (view filing) | Jun 30 | 2 days | Sitko BradleyChief Investment Officer | PPurchaseDepositary Shares - 8.375% Series B Cumulative Stock | +2.00K | $25.39 | +$50.8K | +39.6%7.04K after | |
| May 21, 2025 (view filing) | May 20 | 1 day | Hughes OwenChief Executive Officer | SSale | −25.6K | $25.38 | −$650.7K | −29.0%62.7K after | |
| May 21, 2025 (view filing) | May 20 | 1 day | Burns Thomas M.SVP, Finance & CFO | SSale | −10.5K | $25.38 | −$266.0K | −31.7%22.6K after | |
| May 20, 2025 (view filing)6:56 PM ET | May 16 | 4 days | Biotechnology Value Fund L P and 9 others10% Owner | SSaleCommon Stock, $0.0075 par value per share | −392.7K | $27.10 | −$10.6M | −23.7%1.27M after | 2 lots |
| Apr 9, 2025 (view filing) | Apr 7 | 2 days | Sitko BradleyChief Investment Officer | PPurchaseDepositary Shares - 8.375% Series B Cumulative Stock | +2.00K | $24.70 | +$49.4K | +65.7%5.04K after | |
| Apr 7, 2025 (view filing) | Apr 3-4 | 4 days | Limber Joseph MDirector | PPurchaseDepositary Shares - 8.375% Series B Cumulative Stock | +20.0K | $25.23 | +$504.5K | New position20.0K after | 2 lots |
| Apr 7, 2025 (view filing) | Apr 3-7 | 4 days | Limber Joseph MDirector | PPurchase8.625% Series A Cumulative Perpetual Preferred Stock | +10.0K | $25.56 | +$255.6K | New position10.0K after | 3 lots |
| Apr 2, 2025 (view filing) | Mar 31 | 2 days | Sitko BradleyChief Investment Officer | PPurchase | +1.00K | $19.98 | +$20.0K | +9.5%11.5K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in XOMA Royalty Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 7,593,303 | $322.7M | 8.25% | +5,003,000+193.1% | Added |
| Morgan Stanley | 1,697,167 | $72.1M | 0.00% | −4,990−0.3% | Reduced |
| FMR LLC | 1,605,532 | $68.2M | 0.00% | +302,558+23.2% | Added |
| Woodline Partners LP | 1,114,363 | $47.4M | 0.15% | +474,362+74.1% | Added |
| Newtyn Management, LLC | 709,247 | $30.1M | 3.76% | +709,247 | New |
| BlackRock, Inc. | 691,971 | $29.4M | 0.00% | +45,057+7.0% | Added |
| Vanguard Capital Management LLC | 505,165 | $21.5M | 0.00% | −44,631−8.1% | Reduced |
| Opaleye Management Inc. | 338,374 | $14.4M | 1.30% | +38,374+12.8% | Added |
| Geode Capital Management, LLC | 245,321 | $10.4M | 0.00% | +15,555+6.8% | Added |
| Water Island Capital LLC | 242,000 | $10.3M | 1.09% | +242,000 | New |